Went back and read through some of the recent announcements and saw the endometriosis POC was mentioned as due in the Sept quarter.
I know it's still bit early but seems to coincide? It's too early for Jannsen outcome and all other PromarkerD commercialization announcements didn't require a trading halt, so it has to be something relating to a discovery or fundamental change in the company.
Source: ASX Release30 July 2019
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.8¢ |
Change
-0.008(2.38%) |
Mkt cap ! $50.33M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 30.5¢ | $54.65K | 177.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 45074 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 80222 | 2 |
View Market Depth
| Last trade - 15.52pm 12/09/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |